Several medical societies backed the 2026 AAP childhood vaccine schedule, prioritizing longstanding scientific evidence for pediatric public health protocols.

Previously lecanemab was only approved as an SC injection for maintenance dosing, following an initial 18 month IV phase.

Afrezza is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus.

HealthDay News — Six-month smartwatch-based atrial fibrillation (AF) screening improves detection of new-onset AF among patients at elevated stroke risk, according to a study published online January ...

The between-group difference in restricted mean arthritis-free survival time seen at 2 years persisted at 4 years.

TNS seems safe, with no serious adverse events, but no significant differential treatment effects seen versus sham TNS ...

Amlitelimab is an investigational anti-OX40 ligand monoclonal antibody designed to normalize the overactive immune response in patients with atopic dermatitis.

New research on acetaminophen use during pregnancy; the chikungunya vaccine Ixchiq is withdrawn; FDA approves Nexplanon for up to 5 years of use; suicidal ideation warning removed from GLP-1s; at-home ...

PFS significantly higher with nivolumab, doxorubicin, vinblastine, and dacarbazine versus brentuximab vedotin-AVD.

Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral corticosteroids ...

HealthDay News — Some canned tuna associated with a 2025 recall has been pulled from grocery stores in 9 states, federal ...

More than 80% of patients with clinically meaningful benefit at 12 months maintain that benefit at 18 and 24 months.